FootJoy reveal new 2017 ContourFIT golf shoes


FootJoy reveals new 2017 ContourFIT golf shoes.

The Contour range was created with a focus on comfort, and FootJoy has that dedication continues with the latest innovation, ContourFIT.

Footjoy's designers reimagined the entire category from a blank sheet of paper and they say ContourFIT was born from an obsession with comfort so golfers could experience Comfort That Never Quits.

They say the Contour franchise has been greatly enhanced by significant and noticeable upgrades from top to bottom that result in a lighter, more flexible and more comfortable shoe.

FootJoy 2017 ContourFIT tech at a glance

TPU DynaFlex Outsole
The new DynaFlex outsole has been designed to flex naturally with the foot and each flex groove is strategically placed to provide maximum flexibility and while walking and throughout the golf swing.

FTF 3.0 – Softest, Lightest Midsole Compound
FootJoy say the Fine-Tuned Foam 3.0 (FTF 3.0) provides underfoot comfort and soft cushioning without compromising on support and stability.

New Contour Plus Last, Extra Thick Fitbed
Contour Plus Last offers a full rounded toe character which is full across the forefoot, with a standard instep and heel. The last bottom is contoured to more closely match the shape of the foot whilst an extra depth last is also incorporated to accommodate a thicker fitbed for enhanced cushioning, providing all day breathable comfort, according to FootJoy.

Achilles Pad – Soft, Comfortable Fit
There is anew achilles heel pad in the ContourFIT and FootJoy say it delivers support and comfort whilst working with the connected comfort tongue to lock the foot into the shoe for a precise fit.

The new ContourFIT range is available in the UK from Wednesday March 1st 2017 with an RRP of £120 for the laced model and £135 for the Boa Closure model.

The laced model is available in white and black, black, charcoal and white or white and brown; while the BOA model is only available in black and white.

READ NEXT: TG's biggest ever equipment trial